Study shows superior activity for nab-paclitaxel vs paclitxel in early breast cancer
The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based...